Literature DB >> 18293940

(-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases.

Omari J Bandele1, Neil Osheroff.   

Abstract

(-)-Epigallocatechin gallate (EGCG) is the most abundant and biologically active polyphenol in green tea, and many of the therapeutic benefits of the beverage have been attributed to this compound. High concentrations of EGCG are cytotoxic and trigger genotoxic events in mammalian cells. Although this catechin affects a number of cellular systems, the genotoxic effects of several bioflavonoid-based dietary polyphenols are believed to be mediated, at least in part, by their actions on topoisomerase II. Therefore, the effects of green tea extract and EGCG on DNA cleavage mediated by human topoisomerase IIalpha and beta were characterized. The extract and EGCG increased levels of DNA strand breaks generated by both enzyme isoforms. However, EGCG acted by a mechanism that was distinctly different from those of genistein, a dietary polyphenol, and etoposide, a widely prescribed anticancer drug. In contrast to these agents, EGCG exhibited all of the characteristics of a redox-dependent topoisomerase II poison that acts by covalently adducting to the enzyme. First, EGCG stimulated DNA scission mediated by both isoforms primarily at sites that were cleaved in the absence of compounds. Second, exposure of EGCG to the reducing agent dithiothreitol (DTT) prior to its addition to DNA cleavage assays abrogated the effects of the catechin on DNA scission. Third, once EGCG stimulated topoisomerase II-mediated DNA cleavage, exposure to DTT did not effect levels of DNA strand breaks. Finally, EGCG inhibited the DNA cleavage activities of topoisomerase IIalpha and beta when incubated with either enzyme prior to the addition of DNA. Taken together, these results provide strong evidence that EGCG is a redox-dependent topoisomerase II poison and utilizes a mechanism similar to that of 1,4-benzoquinone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293940      PMCID: PMC2893035          DOI: 10.1021/tx700434v

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  97 in total

1.  Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals.

Authors:  S Valcic; A Muders; N E Jacobsen; D C Liebler; B N Timmermann
Journal:  Chem Res Toxicol       Date:  1999-04       Impact factor: 3.739

Review 2.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

Review 3.  Mutagenic properties of topoisomerase-targeted drugs.

Authors:  B C Baguley; L R Ferguson
Journal:  Biochim Biophys Acta       Date:  1998-10-01

Review 4.  Type II DNA topoisomerases.

Authors:  J M Berger
Journal:  Curr Opin Struct Biol       Date:  1998-02       Impact factor: 6.809

5.  Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha.

Authors:  R K Baker; E U Kurz; D W Pyatt; R D Irons; D J Kroll
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

6.  Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.

Authors:  P S Kingma; C A Greider; N Osheroff
Journal:  Biochemistry       Date:  1997-05-20       Impact factor: 3.162

Review 7.  Topoisomerase II and the etiology of chromosomal translocations.

Authors:  Carolyn A Felix; Christos P Kolaris; Neil Osheroff
Journal:  DNA Repair (Amst)       Date:  2006-07-20

8.  Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.

Authors:  R A Isbrucker; J A Edwards; E Wolz; A Davidovich; J Bausch
Journal:  Food Chem Toxicol       Date:  2006-01-04       Impact factor: 6.023

9.  Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405.

Authors:  Ryan P Bender; Amy-Joan L Ham; Neil Osheroff
Journal:  Biochemistry       Date:  2007-02-14       Impact factor: 3.162

10.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.

Authors:  Jungil Hong; Hong Lu; Xiaofeng Meng; Jae-Ha Ryu; Yukihiko Hara; Chung S Yang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

View more
  35 in total

1.  Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.

Authors:  Adam C Ketron; William A Denny; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2012-02-10       Impact factor: 3.162

2.  The impact of green tea polyphenols on development and reproduction in Drosophila melanogaster.

Authors:  Terry E Lopez; Hoang M Pham; Julia Barbour; Phillip Tran; Benjamin Van Nguyen; Sean P Hogan; Richelle L Homo; Volkan Coskun; Samuel E Schriner; Mahtab Jafari
Journal:  J Funct Foods       Date:  2016-01-01       Impact factor: 4.451

3.  DNA Topology and Topoisomerases: Teaching a "Knotty" Subject.

Authors:  Joseph E Deweese; Michael A Osheroff; Neil Osheroff
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

Review 4.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 5.  Recognition and repair of chemically heterogeneous structures at DNA ends.

Authors:  Sara N Andres; Matthew J Schellenberg; Bret D Wallace; Percy Tumbale; R Scott Williams
Journal:  Environ Mol Mutagen       Date:  2014-08-11       Impact factor: 3.216

6.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

7.  Oxidative metabolites of curcumin poison human type II topoisomerases.

Authors:  Adam C Ketron; Odaine N Gordon; Claus Schneider; Neil Osheroff
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

8.  Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

Authors:  J J Bower; G F Karaca; Y Zhou; D A Simpson; M Cordeiro-Stone; W K Kaufmann
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

9.  The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Biochemistry       Date:  2008-10-16       Impact factor: 3.162

10.  Cleavage of plasmid DNA by eukaryotic topoisomerase II.

Authors:  Omari J Bandele; Neil Osheroff
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.